Industry / Ecuador
First Compulsory Licence Granted
April 2010 | Industry Trend AnalysisEcuador has granted its first compulsory licence for a patented pharmaceutical since the Ecuadorian President Rafael Correa signed decree 118 on 23 October 2009.[1] The licence was granted for antiretroviral drug ritonavir, to Eskegroup, the local distributor for Cipla, an Indian generic pharmaceutical producer.
To read the full article, please choose one of the following options:
Subcribers please log in




